Company: NCEL
Filing Date: 2025-09-25
Form Type: F-1
Source: 0001213900-25-091697
Chunk: 62

Company: NewcelX Ltd.
Filing Date: 2025-09-25
Form: F-1
Chunk 62
---
 Alpha Capital Anstalt (3)   |     |                     | 424,777 |     |         | 9.99 | % |     |               | 5,000,000 |     |                  0 |     |       0 | % |

| (1) | We have excluded from the number                                                                                                           
 of shares beneficially owned prior to the offering all of the shares that the Selling Shareholder may be required to purchase under the    
 Purchase Agreement, because the issuance of such shares is solely at our discretion and is subject to conditions contained in the Purchase 
 Agreement, the satisfaction of which are entirely outside of the Selling Shareholder’s control, including the prospectus that includes     
 this prospectus becoming and remaining effective.                                                                                          |

| (2) | Assumes the sale of all shares                                                                                                             
 being offered pursuant to this prospectus. Depending on the price per share at which we sell our Common Shares to the Selling Shareholder  
 pursuant to the Purchase Agreement, we may need to sell to the Selling Shareholder under the Purchase Agreement more shares of our Common  
 Shares than are offered under this prospectus in order to receive aggregate gross proceeds equal to the $25.0 million total commitment     
 under the Purchase Agreement. If we choose to do so and otherwise satisfy the conditions in the Purchase Agreement, we must first register 
 for resale under the Securities Act such additional shares. The number of shares ultimately offered for resale by the Selling Shareholder  
 is dependent upon the number of shares we sell to the Selling Shareholder under the Purchase Agreement.                                    |

| (3) | Consists of (i) 781,190 Common Shares issuable upon conversion of NLS                                                                
 Preferred Shares within 60 days of September 24, 2025, (ii) 738,676 Common Shares issuable upon exercise of common warrants within   
 60 days of September 24, 2025, (iii) 400,023 Common Shares issuable upon conversion of 370,093 PPCs within 60 days of September 24,  
 2025, and (iv) 677,308 Common Shares issuable upon exercise of pre-funded warrants within 60 days of September 24, 2025. The NLS     
 Preferred Shares, PPCs, and common warrants are subject to a beneficial ownership limitation of 9.99%, and the pre-funded warrants   
 are subject to a beneficial ownership limitation of 4.99% (or upon election of Alpha, 9.99%). Such